Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Superficial venous ablation · Georgia | Superficial venous ablation · Florida | |
|---|---|---|
| Surgeons, 2024 | 64 | 243 |
| Medicare fee-for-service cases | 4,583 | 23,074 |
| Growth since 2019 (Medicare FFS) | −7.7%/yr | −4.3%/yr |
| Forecast cases (Medicare FFS) | 5,820 in 2030 | 26,100 in 2030 |
| Forecast growth | +4.1%/yr to 2030 | +2.1%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 5.0 | 9.8 |
| Medicare Advantage share | 59% | 60% |
| Out of hospital | 100% (+1 pts since 2019) | 100% (+1 pts since 2019) |
| Cases per surgeon | 72 | 95 |
| Top 10 surgeons' share | 49% | 25% |
| Surgeons growing | 11 | 48 |
| New since the base year | 12 | 49 |
| Likely to stop billing it | 13 by 2026 | 40 by 2026 |
| Forecast miss, 1 year (procedure) | 5% | 5% |
| Company payments per surgeon | $896 | $374 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.